Morozko Eva L, Ochaba Joseph, Hernandez Sarah J, Lau Alice, Sanchez Isabella, Orellana Iliana, Kopan Lexi, Crapser Joshua, Duong Janet H, Overman Julia, Yeung Silvia, Steffan Joan S, Reidling Jack, Thompson Leslie M
University of California, Irvine, Neurobiology and Behavior, Irvine, CA, USA.
University of California, Irvine, Psychiatry & Human Behavior, Irvine, CA, USA.
J Huntingtons Dis. 2018;7(4):321-335. doi: 10.3233/JHD-180329.
Biochemical analysis of mutant huntingtin (mHTT) aggregation species in HD mice is a common measure to track disease. A longitudinal and systematic study of how tissue processing affects detection of conformers has not yet been reported. Understanding the homeostatic flux of mHTT over time and under different processing conditions would aid in interpretation of pre-clinical assessments of disease interventions.
Provide a systematic evaluation of tissue lysis methods and molecular and biochemical assays in parallel with behavioral readouts in R6/2 mice to establish a baseline for HTT exon1 protein accumulation.
Established biochemical methods were used to process tissue from R6/2 mice of specific ages following behavior tasks. Aggregation states and accumulation of mHTT exon 1 protein were evaluated using multiple break and assay methods to determine potential conformational flux assay specificity in detection of mHTT species, and tissue specificity of conformers.
Detection of mHTT exon 1 protein species varied based on biochemical processing and analysis providing a baseline for subsequent studies in R6/2 mice. Insoluble, high molecular weight species of mHTT exon 1 protein increased and tracked with onset of behavioral impairments in R6/2 mice using multiple assay methods.
Conformational flux from soluble monomer to high molecular weight, insoluble species of mHTT exon 1 protein was generally consistent for multiple assay methods throughout R6/2 disease progression; however, the results support the use of multiple biochemical techniques to detect mHTT exon 1 protein species for preclinical assessments in HD mouse models expressing mHTT exon 1 protein.
对亨廷顿舞蹈症(HD)小鼠模型中突变型亨廷顿蛋白(mHTT)聚集物进行生化分析是追踪该疾病的常用手段。目前尚未有关于组织处理如何影响构象异构体检测的纵向系统研究报道。了解mHTT在不同时间和不同处理条件下的稳态变化,将有助于解释疾病干预的临床前评估结果。
与R6/2小鼠的行为学指标同步,对组织裂解方法以及分子和生化检测进行系统评估,以建立HTT外显子1蛋白积累的基线。
采用既定的生化方法,在行为任务后处理特定年龄R6/2小鼠的组织。使用多种裂解和检测方法评估mHTT外显子1蛋白的聚集状态和积累情况,以确定检测mHTT聚集物时潜在的构象变化检测特异性以及构象异构体的组织特异性。
mHTT外显子1蛋白聚集物的检测结果因生化处理和分析方法而异,为后续R6/2小鼠研究提供了基线。使用多种检测方法发现,R6/2小鼠中mHTT外显子1蛋白的不溶性高分子量聚集物增加,并与行为障碍的出现相关。
在整个R6/2疾病进展过程中,多种检测方法检测到的mHTT外显子1蛋白从可溶性单体到高分子量不溶性聚集物的构象变化总体上是一致的;然而,研究结果支持在表达mHTT外显子1蛋白的HD小鼠模型中,使用多种生化技术检测mHTT外显子1蛋白聚集物用于临床前评估。